HealthPhoto: Firstpost HealthFDA Warns of Rare Eye Condition Linked to Ozempic and Similar Drugs
The US FDA has directed all GLP-1 drug manufacturers to add warnings about the risk of NAION, a rare optic nerve disorder causing sudden vision loss in one eye. This advisory affects drugs like Ozempic, Wegovy, and Mounjaro. Patients are advised to consult healthcare providers before stopping these medications despite the warning.
Firstpost Health·



